Vericel Corp Ord Stock Z Score
| VCEL Stock | USD 34.24 0.62 1.84% |
Vericel | Z Score |
Vericel Z Score Analysis
Vericel Corp's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
More About Z Score | All Equity Analysis
| 2020 | 2021 | 2022 | 2023 (projected) | Tangible Asset Value | 205.6M | 243.7M | 265.5M | 286.5M | Market Capitalization | 1.4B | 1.8B | 1.2B | 995.9M |
Z Score | = | Sum Of | | 5 Factors |
Current Vericel Corp Z Score | 19.41 |
Most of Vericel Corp's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vericel Corp Ord is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
Vericel Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Vericel Corp is extremely important. It helps to project a fair market value of Vericel Stock properly, considering its historical fundamentals such as Z Score. Since Vericel Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vericel Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vericel Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
As per the company's disclosures, Vericel Corp Ord has a Z Score of 19.41. This is 187.56% higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The z score for all United States stocks is 122.59% lower than that of the firm.
Vericel Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vericel Corp's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics of similar companies.Vericel Corp is currently under evaluation in z score category among related companies.
Vericel Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vericel Corp from analyzing Vericel Corp's financial statements. These drivers represent accounts that assess Vericel Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vericel Corp's important valuation drivers and their relationship over time.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||
| Net Income Per Employee | (37.7K) | (40.1K) | 10.5K | (26.6K) | (54.8K) | (59.1K) | |
| Revenue Per Employee | 420.6K | 489.0K | 453.6K | 555.8K | 538.9K | 581.4K | |
| Average Assets | 104.4M | 139.5M | 165.0M | 225.3M | 251.5M | 271.4M | |
| Earnings Before Interest Taxes and Depreciation Amortization EBITDA | (5.0M) | (5.1M) | 5.4M | (4.6M) | (11.6M) | (12.6M) | |
| Earnings Before Interest Taxes and Depreciation Amortization USD | (5.0M) | (5.1M) | 5.4M | (4.6M) | (11.6M) | (12.6M) | |
| Earnings before Tax | (8.1M) | (9.7M) | 3.0M | (7.6M) | (16.0M) | (17.3M) | |
| Average Equity | 77.1M | 99.9M | 116.7M | 154.6M | 179.4M | 193.5M | |
| Enterprise Value | 718.2M | 768.9M | 1.4B | 1.8B | 1.2B | 977.5M | |
| Free Cash Flow | (3.1M) | (9.8M) | 14.9M | 21.1M | 10.1M | 10.9M | |
| Invested Capital | 85.6M | 134.2M | 202.5M | 199.2M | 224.5M | 242.3M | |
| Invested Capital Average | 53.6M | 123.8M | 133.8M | 195.1M | 210.0M | 226.6M | |
| Market Capitalization | 754.2M | 777.7M | 1.4B | 1.8B | 1.2B | 995.9M | |
| Tangible Asset Value | 118.7M | 153.2M | 205.6M | 243.7M | 265.5M | 286.5M | |
| Working Capital | 98.0M | 91.9M | 101.1M | 132.4M | 149.4M | 161.2M |
Vericel Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Vericel Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vericel Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vericel Corp's value.| Shares | Geode Capital Management, Llc | 2023-09-30 | 977.2 K | Bnp Paribas Investment Partners Sa | 2023-09-30 | 923.2 K | William Blair Investment Management, Llc | 2023-09-30 | 855.2 K | Dimensional Fund Advisors, Inc. | 2023-09-30 | 722.3 K | Ameriprise Financial Inc | 2023-09-30 | 714 K | Jpmorgan Chase & Co | 2023-09-30 | 630.7 K | Point72 Asset Management, L.p. | 2023-09-30 | 617.6 K | Nuveen Asset Management, Llc | 2023-09-30 | 602.4 K | Fmr Inc | 2023-09-30 | 571.3 K | Blackrock Inc | 2023-09-30 | 7.5 M | Brown Capital Management, Llc | 2023-09-30 | 6.9 M |
Vericel Fundamentals
| Return On Equity | -0.0537 | ||||
| Return On Asset | -0.029 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 1.58 B | ||||
| Shares Outstanding | 47.72 M | ||||
| Shares Owned By Insiders | 0.81 % | ||||
| Shares Owned By Institutions | 99.19 % | ||||
| Number Of Shares Shorted | 6.01 M | ||||
| Price To Earning | 357.33 X | ||||
| Price To Book | 7.84 X | ||||
| Price To Sales | 8.73 X | ||||
| Revenue | 164.37 M | ||||
| Gross Profit | 109.79 M | ||||
| EBITDA | (15.62 M) | ||||
| Net Income | (16.71 M) | ||||
| Cash And Equivalents | 100.69 M | ||||
| Cash Per Share | 2.13 X | ||||
| Total Debt | 47.57 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 4.29 X | ||||
| Cash Flow From Operations | 17.69 M | ||||
| Short Ratio | 17.78 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 42.58 | ||||
| Number Of Employees | 305 | ||||
| Beta | 1.58 | ||||
| Market Capitalization | 1.62 B | ||||
| Total Asset | 273 M | ||||
| Retained Earnings | (400 M) | ||||
| Working Capital | 149.4 M | ||||
| Current Asset | 21.1 M | ||||
| Current Liabilities | 15.36 M | ||||
| Z Score | 19.41 | ||||
| Annual Yield | 0.03 % | ||||
| Net Asset | 273 M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.
Vericel Corp Investors Sentiment
The influence of Vericel Corp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vericel. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Vericel Corp's public news can be used to forecast risks associated with an investment in Vericel. The trend in average sentiment can be used to explain how an investor holding Vericel can time the market purely based on public headlines and social activities around Vericel Corp Ord. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Vericel Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vericel Corp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Vericel Corp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Vericel Corp.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vericel Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vericel Corp's short interest history, or implied volatility extrapolated from Vericel Corp options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:Check out Vericel Corp Piotroski F Score and Vericel Corp Valuation analysis. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.343 | Earnings Share (0.21) | Revenue Per Share 3.902 | Quarterly Revenue Growth 0.182 | Return On Assets (0.03) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.